Confirmed Control Announced Transaction verified CPGMicrobiome SupplementsProbioticsProbiotics / Microbiome Supplements
Microbiome Labs acquired by Novozymes
Novozymes agreed to acquire Microbiome Labs, a US probiotics / microbiome supplements brand, on Jan 6, 2021.
Transaction summary
- Target
- Microbiome Labs
- Acquirer
- Novozymes
- Seller
- -
- Announced
- 2021-01-06
- Geography
- United States
- Tags
- CPGMicrobiome SupplementsProbioticsProbiotics / Microbiome Supplements
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
USD 125M
Consideration | USD
Basis: Public source
Price / revenue
3.1x
Period not stated
Basis: FundComb estimate
Price / EBITDA
6x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 125m consideration is treated as publicly disclosed or derived directly from public source data.
- Price / revenue: 3.1x.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- Price / EBITDA: 6x.
Source summary
No public source summary has been published for this transaction yet.